AXIM Biotechnologies, Inc.

AXIM ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
8-K/A May 29, 2014 FORM 8-K
UPLOAD May 28, 2014
PRE 14C May 23, 2014 PRE 14C
CORRESP May 23, 2014
8-K May 23, 2014 FORM 8-K
10-Q May 20, 2014 FORM 10-Q (3-31-14)
8-K May 20, 2014 FORM 8-K
UPLOAD May 20, 2014
NT 10-Q May 14, 2014 FORM 12B-25 (3-31-14)
PRE 14C May 2, 2014 PRELIMINARY 14C INFORMATION STATEMENT
4 Apr 30, 2014 PRIMARY DOCUMENT
SC 13D Apr 28, 2014 SCHEDULE 13D
3 Apr 25, 2014 PRIMARY DOCUMENT
3 Apr 25, 2014 PRIMARY DOCUMENT
3 Apr 25, 2014 PRIMARY DOCUMENT
3 Apr 25, 2014 PRIMARY DOCUMENT
3 Apr 25, 2014 PRIMARY DOCUMENT
SC 13D Apr 25, 2014 SCHEDULE 13D
8-K Apr 1, 2014 FORM 8-K
10-K Mar 4, 2014
5 Jan 28, 2014 PRIMARY DOCUMENT
10-Q Nov 18, 2013
NT 10-Q Nov 8, 2013
10-Q Aug 14, 2013
NT 10-Q Aug 12, 2013
← Newer Page 11 of 13 · 306 filings Older →